Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
The phosphoinositide-3-kinase (PI3K)/Akt signaling pathway plays an important role in cell survival and the development of cancer. Macrophage migration inhibitory factor (MIF) is a critical inflammatory cytokine that was recently associated with tumorigenesis and that potently inhibits apoptosis. This may involve inhibition of p53-dependent genes, but the initiating molecular mechanism of how MIF controls survival/apoptosis is unknown. Here, we show that MIF prevents apoptosis and promotes tumor cell survival by directly activating the Akt pathway. MIF enhanced Akt activity in primary and immortalized fibroblasts (MEF and NIH/3T3), HeLa cervix carcinoma cells and various breast cancer cell lines. Activation was abolished by kinase inhibitors Ly294002 and PP2 and in Src/Yes/Fyn(SYF)(-/-) and CD74(-/-)(MEFs), while being enhanced in CD74-overexpressing MEFs, demonstrating that the MIF-induced Akt pathway encompasses signaling through the MIF receptor CD74 and the upstream kinases Src and PI3K. Akt was activated by exogenous rMIF and autocrine MIF action, as revealed by experiments in MIF(-/-)MEFs and antibody blockade. siRNA knockdown of CSN5/JAB1, a tumor marker and MIF-binding protein, showed that JAB1 controls autocrine MIF-mediated Akt signaling by inhibition of MIF secretion. Akt activation by MIF led to phosphorylation of the proapoptotic proteins BAD and Foxo3a. Apoptosis inhibition by MIF was functionally associated with Akt activation as it was abolished by overexpression of the Akt pathway inhibitor PTEN and occurred independently of p53. This was shown by studying DNA damage-induced apoptosis in fibroblasts, the Fas death pathway in HeLa cells that do not express functional p53, and etoposide-induced apoptosis in breast carcinoma cells expressing mutant p53. Importantly, dependence of breast cancer cell survival on MIF correlated with Akt activation and the PTEN status of these cells. Thus, MIF can directly promote cell survival through activation of the PI3K/Akt pathway and this effect is critical for tumor cell survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MIF is elevated in the AD brain and mediates pro-inflammatory signaling by promoting the secretion of IL-6 and TNF-α [46].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [46]
Citations
Cites
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
The activation of Akt/PKB signaling pathway and cell survival
Song, G., Ouyang, G., & Bao, S. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00337.x · Cited by 1,888
Macrophage migration inhibitory factor: a regulator of innate immunity
Calandra, T., & Roger, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1200 · Cited by 1,795
PI3K-Akt pathway: Its functions and alterations in human cancer
Osaki, M., Oshimura, M., & Ito, H. (2004) · Apoptosis · doi:10.1023/b:appt.0000045801.15585.dd · Cited by 1,264
Chang, F., Lee, J. T., Navolanic, P. M., Steelman, L. S., Shelton, J. G., Blalock, W. L., Franklin, R. A., & McCubrey, J. A. (2003) · Leukemia · doi:10.1038/sj.leu.2402824 · Cited by 1,176
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
Self-citationRole of Akt Signaling in Vascular Homeostasis and Angiogenesis
Shiojima, I., & Walsh, K. (2002) · Circulation Research · doi:10.1161/01.res.0000022200.71892.9f · Cited by 1,012
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 999
Self-citationAngiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF)
Byrne, A. M., Bouchier-Hayes, D. J., & Harmey, J. H. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00379.x · Cited by 744
Mechanism of activation and function of protein kinase B
Alessi, D. R., & Cohen, P. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80062-2 · Cited by 743
Cited by
Items 101–200 of 395
Pasupuleti, V., Du, W., Gupta, Y., Yeh, I., Montano, M. M., Magi-Galuzzi, C., & Welford, S. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500694 · Cited by 58
“MIF has been linked to induction of apoptosis in a number of other systems (23, 24).”
BackgroundInhibition of MIF Leads to Cell Cycle Arrest and Apoptosis in Pancreatic Cancer Cells
Denz, A., Pilarsky, C. P., Muth, D., Rückert, F., Saeger, H., & Grützmann, R. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.048 · Cited by 54
Liao, B., Zhong, B., Li, Z., Tian, X., Li, Y., & Li, B. (2010) · Journal of Surgical Oncology · doi:10.1002/jso.21728 · Cited by 52
“Accumulated researches also show MIF can modulate cell biological behaviors by activating the NF-kB, Erk1/2, AP-1, and PI3K/Akt pathway, which is similar to the IL-8 mechanism [12,14].”
BackgroundResultIdentification of Breast Cancer Peptide Epitopes Presented by HLA-A*0201
Hawkins, O. E., VanGundy, R. S., Eckerd, A., Bardet, W., Buchli, R., Weidanz, J. A., & Hildebrand, W. H. (2008) · Journal of Proteome Research · doi:10.1021/pr700761w · Cited by 56
Koida, N., Ozaki, T., Yamamoto, H., Ono, S., Koda, T., Ando, K., Okoshi, R., Kamijo, T., Omura, K., & Nakagawara, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710608200 · Cited by 51
Lugrin, J., Ding, X. C., Roy, D. L., Chanson, A.-L., Sweep, F. C. G. J., Calandra, T., & Roger, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.007 · Cited by 53
“MIF stimulates cell proliferation through a sustained activation of the ERK1/2 MAPKs [4] and the induction of cyclin D1 (CCND1) [5] and promotes cell survival by inhibiting the p53 and retinoblastoma/E2F tumor suppressor pathways [6–8] and by activating the phosphoinositide-3-kinase (PI3K)/ Akt survival pathway [9].”
BackgroundGarai, J., & Lóránd, T. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787581842 · Cited by 52
Vera, P. L., Iczkowski, K. A., Wang, X., & Meyer‐Siegler, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003898 · Cited by 53
Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor
Trivedi‐Parmar, V., & Jorgensen, W. L. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00589 · Cited by 55
Cotzomi-Ortega, I., Nieto-Yáñez, Ó., Juárez‐Avelar, I., Rojas-Sánchez, G., Montes-Alvarado, J. B., Reyes‐Leyva, J., Aguilar‐Alonso, P., Rodríguez‐Sosa, M., & Maycotte, P. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110075 · Cited by 57
Song, S., Liu, B., Habibie, H., van den Bor, J., Smit, M. J., Gosens, R., Wu, X., Brandsma, C., Cool, R. H., Haisma, H. J., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103412 · Cited by 48
“Association of BAD with Bcl-2 or Bcl-xL triggers cytochrome C release by mitochondria and subsequently induces apoptosis and BAD phosphorylation inhibits this [27,28].”
ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone
Mourskaia, A., Amir, E., Dong, Z., Tiedemann, K., Cory, S. M., Ömeroğlu, A., Bertos, N., Ouellet, V., Clemons, M. J., Scheffer, G. L., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3361 · Cited by 52
“It has been shown that MIF promotes breast cancer cell proliferation [52,53], angiogenesis [54], and survival [55].”
BackgroundPalumbo, S. L., Tsai, T.-L., & Li, W. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0294 · Cited by 55
“In addition to the identified mechanism that extracellular MIF binds to its receptor CD74 to induce AKT activation [51,52], it is likely that MIF can activate intracellular mechanisms to modulate cellular senescence of hMSCs in hypoxic culture.”
Role of macrophage migration inhibitory factor in age-related lung disease
Sauler, M., Bucala, R., & Lee, P. J. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00339.2014 · Cited by 55
“In addition to mediating MIF’s involvement in host immunity and inflammation, these pathways are also implicated in MIF’s role in cell survival and angiogenesis (79, 80, 93).”
Self-citationEndothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury
Sauler, M., Zhang, Y., Min, J., Leng, L., Shan, P., Roberts, S. J., Jorgensen, W. L., Bucala, R., & Lee, P. J. (2015) · The FASEB Journal · doi:10.1096/fj.14-260299 · Cited by 54
Self-citationJung, H., Seong, H., & Ha, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806225200 · Cited by 57
The role of MIF in chronic lung diseases: looking beyond inflammation
Florez-Sampedro, L., Soto-Gamez, A., Poelarends, G. J., & Melgert, B. N. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00521.2019 · Cited by 47
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer
Hamidi, A. A., Taghehchian, N., Basirat, Z., Zangouei, A. S., & Moghbeli, M. (2022) · Biomarker Research · doi:10.1186/s40364-022-00382-4 · Cited by 48
“MIF is a pivotal pro-inflammatory cytokine during tumor progression and growth by AKT activation [156].”
BackgroundTaylor, J. A., Kuchel, G. A., Hegde, P., Voznesensky, O. S., Claffey, K. P., Tsimikas, J., Leng, L., Bucala, R., & Pilbeam, C. C. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-135 · Cited by 47
“In addition, MIF has recently been shown to promote survival in fibroblasts via a phosphoinositide-3-kinase (PI3K)/Akt signaling pathway [15].”
Self-citationMacrophage migration inhibitory factor induces vascular leakage via autophagy
Chen, H., Chuang, Y., Chao, C.-H., & Yeh, T. (2015) · Biology Open · doi:10.1242/bio.201410322 · Cited by 50
“The binding of MIF to CXCR2, CXCR4 and/or CD74 induces the activation of PI3K/Akt and MAPK/ERK (Bernhagen et al., 2007; Schwartz et al., 2009; Lue et al., 2006; Lue et al., 2007).”
BackgroundRenner, P., Roger, T., Bochud, P., Sprong, T., Sweep, F. C. G. J., Bochud, M., Faust, S. N., Haralambous, E., Betts, H., Chanson, A.-L., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-195065 · Cited by 49
The Role of Adipokines and Bone Marrow Adipocytes in Breast Cancer Bone Metastasis
Shin, E., & Koo, J. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144967 · Cited by 50
“MIF promotes breast cancer cell proliferation by activation of PI3K/AKT signaling pathway [80] promotes tumor growth and metastasis by increasing recruitment of myeloid-derived suppressor cells [81] involved in pre-metastatic niche of bone metastasis process by intravasation, angiogenesis and EMT in breast cancer CTC…”
BackgroundMartinez, L. M., Vallone, V. B. F., Labovsky, V., Choi, H., Hofer, E. L., Feldman, L. J., Bordenave, R. H., Batagelj, E., Dimase, F., Villafañe, A. R., et al. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9622-5 · Cited by 51
“Moreover, MIF and OPG are not only pro-angiogenic factors [18, 19] but also have an anti-apoptotic effect over BCCs favouring circulating BCC survival [20, 21].”
BackgroundZhang, W., Huang, J., Tian, X.-Y., Liu, Y.-H., Jia, M.-Q., Wang, W., Jin, C., Song, J., & Zhang, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115673 · Cited by 46
Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy
Koga, K., Kenessey, Á., & Ojamaa, K. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00595.2012 · Cited by 47
“MIF receptor-initiated activation of PKB/Akt has been described in proliferative cells (28); however, this signaling pathway is unlikely to explain the robust hypertrophic response in MIF KO hearts in the present study, even though CD74 expression was upregulated.”
BackgroundXu, X., & Ren, J. (2015) · International Journal of Obesity · doi:10.1038/ijo.2014.174 · Cited by 45
The emerging roles of Jab1/CSN5 in cancer
Wang, L., Zheng, J., & Pei, D. (2016) · Medical Oncology · doi:10.1007/s12032-016-0805-1 · Cited by 46
Ives, A., Roy, D. L., Théroude, C., Bernhagen, J., Roger, T., & Calandra, T. (2021) · The FASEB Journal · doi:10.1096/fj.202001605r · Cited by 54
Self-citationChuang, C., Chuang, Y.-C., Chang, W., Chen, C.-C., Hor, L., Huang, A.-M., Choi, P.-C., Wang, C., Tseng, P.-C., & Lin, C. (2010) · BMC Immunology · doi:10.1186/1471-2172-11-50 · Cited by 47
Macrophage-migration inhibitory factor: role in inflammatory diseases and graft rejection
Javeed, A., Zhao, Y. X., & Zhao, Y. X. (2008) · Inflammation Research · doi:10.1007/s00011-007-7110-6 · Cited by 47
Xiao-juan, P. E. I., Wu, T., Li, B., Tian, X.-Y., Zhi, L. I., & Qing-xu, Y. A. N. G. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.7264 · Cited by 42
Schinagl, A., Thiele, M., Douillard, P., Völkel, D., Kenner, L., Kazemi, Z., Freissmuth, M., Scheiflinger, F., & Kerschbaumer, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11970 · Cited by 42
“Mechanistically, these anti-oxMIF antibodies inhibited proliferation and survival signaling pathways and reduced the level of active ERK1/2 and active Akt, and led to an accumulation of active caspase 3 [42], which is in line with reports on the effects of neutralizing biologic activity of MIF [12, 14].”
BackgroundSelf-citationZheng, S., Ren, X., Tingting, H., Chen, Y., Qiu, H., Liu, W., & Hu, Y. (2017) · Metabolism · doi:10.1016/j.metabol.2017.09.001 · Cited by 42
Klasen, C., Ziehm, T., Huber, M., Asare, Y., Kapurniotu, A., Shachar, I., Bernhagen, J., & Bounkari, O. E. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.02.010 · Cited by 44
Self-citationThe pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer
Guo, Z., Wang, Y., Zhao, Y., Shu, Y., Liu, Z., Zhou, H., Wang, H., & Zhang, W. (2018) · Gene · doi:10.1016/j.gene.2018.11.061 · Cited by 44
miRNA-Directed Regulation of the Main Signaling Pathways in Thyroid Cancer
Ramírez-Moya, J., & Santisteban, P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00430 · Cited by 48
Tawadros, T., Alonso, F., Jichlinski, P., Clarke, N. W., Calandra, T., Haefliger, J., & Roger, T. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0286 · Cited by 44
“Moreover, MIF has been shown to activate the AKT and ERK1/2 pathways in several cell types (Mitchell et al. 1999, Lue et al. 2007).”
BackgroundFu, Q., Li, Y., Jiang, H., Shen, Z., Gao, R., He, Y., Liu, Y., Xu, K., & Yang, T. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.06.124 · Cited by 42
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer
Wen, Y., Cai, W., Yang, J., Fu, X., Putha, L., Xia, Q., Windsor, J. A., Phillips, A. R. J., Tyndall, J. D. A., Du, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638950 · Cited by 44
Wang, X.-B., Tian, X. Y., Li, Y., Ли, Б., & Li, Z. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-011-0640-3 · Cited by 46
“likely to influence the prognosis of glioma patients by the way of an autocrine regulatory loop [8, 13].”
Frölich, D., Blaßfeld, D. A. K., Reiter, K., Giesecke‐Thiel, C., Daridon, C., Mei, H. E., Burmester, G. R., Goldenberg, D. M., Salama, A., & Dörner, T. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3767 · Cited by 43
“Preincubation with a neutralizing monoclonal anti-CXCR4 antibody completely blocked the upregulation of JNK phosphorylation after MIF exposure in Jurkat T cells [33].”
Beswick, E. J., & Reyes, V. E. (2008) · Infection and Immunity · doi:10.1128/iai.01534-07 · Cited by 42
“The EGFR is highly expressed on the surface of cancer cells and, when activated, induces signaling pathways linked to cellular proliferation, such as the Erk1/2 and AKT signaling pathways (19, 20, 24, 29, 30).”
BackgroundDu, W., Wright, B. M., Li, X., Finke, J. H., Rini, B. I., Zhou, M., He, H., Lal, P., & Welford, S. M. (2012) · Oncogene · doi:10.1038/onc.2012.143 · Cited by 42
Morris, K. T., Nofchissey, R. A., Pinchuk, I. V., & Beswick, E. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098656 · Cited by 41
Sarkar, S., Siddiqui, A. A., Mazumder, S., De, R., Saha, S. J., Banerjee, C., Iqbal, M. S., Adhikari, S. S., Alam, A., Roy, S., et al. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00921 · Cited by 40
Involvement of CD74 in head and neck squamous cell carcinomas
Kindt, N., Lechien, J. R., Nonclercq, D., Laurent, G., & Saussez, S. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1648-9 · Cited by 37
Liu, Y.-H., Lin, C.-Y., Lin, W., Tang, S.-W., Lai, M., & Lin, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6584 · Cited by 42
“Previous papers have shown that Ras/Raf/MEK/ERK and PI3K/ AKT kinase signaling pathways are involved in CD74-mediated cellular function (34, 35) through association with CD44 (36, 37).”
BackgroundFazzi, F., Njah, J., Giuseppe, M. D., Winnica, D., Go, K. L., Sala, E., Croix, C. M. S., Watkins, S. C., Tyurin, V. A., Phinney, D. G., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1103516 · Cited by 39
“Among the inflammatory mediators, macrophage migration inhibitory factor can enhance TNF production following LPS stimulation and macrophage survival (43).”
Background4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas
Varinelli, L., Caccia, D., Volpi, C. C., Caccia, C., Bortoli, M. D., Taverna, E., Gualeni, A. V., Leoni, V., Gloghini, A., Manenti, G., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0299 · Cited by 40
“Indeed, MIF inhibits p53-dependent gene expression and suppresses apoptosis associated with p53 activation and redox stress (Lue et al. 2007).”
Xu, S., Guo, X., Gao, X. C., Xue, H., Zhang, J., Guo, X., Qiu, W., Zhang, P., & Li, G. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3704 · Cited by 42
“MIF exhibits a broad spectrum of pro-neoplastic activities, enhancing tumour cell proliferation (11), inducing angiogenesis (12), and reducing tumour cell death by inhibition of p53 (13).”
BackgroundMacrophage migration inhibitory factor expression in cervical cancer
Krockenberger, M., Engel, J. B., Kolb, J., Dombrowski, Y., Häusler, S. F., Kohrenhagen, N., Dietl, J., Wischhusen, J., & Hönig, A. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0702-5 · Cited by 37
“In breast cancer cells, it was recently demonstrated that MIF can directly promote cell survival through activation of the PI3K/Akt pathway demonstrating a link between MIF and PI3K/Akt, which has been shown to play a key role in various malignancies (Lue et al. 2007).”
BackgroundWang, D., Wang, R., Huang, A., Fang, Z., Wang, K., He, M., Xia, J.-T., & Li, W. (2018) · Oncology Reports · doi:10.3892/or.2018.6703 · Cited by 40
Liu, W.-T., Lv, Y., Yang, R., Fu, J., Liu, L., Wang, H., Cao, Q., Tan, C., Chen, H., & Wang, X. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1325-z · Cited by 39
MIF contribution to progressive brain diseases
Matejuk, A., Benedek, G., Bucala, R., Matejuk, S., Offner, H., & Vandenbark, A. A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02993-6 · Cited by 42
“MIF activates MAPK and PI3K pathways involved in signal transduction cascades in many cancers [103, 121, 129–131].”
BackgroundSelf-citationGremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival
Müller, I. I., Chatterjee, M., Schneider, M., Borst, O., Seizer, P., Schönberger, T., Vogel, S., Müller, K., Geisler, T., Lang, F. J. W., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.051 · Cited by 35
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer
Subbannayya, T., Leal, P., Barbhuiya, M. A., Raja, R., Renuse, S., Sathe, G. J., Pinto, S. M., Syed, N., Nanjappa, V., Patil, A. H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1855-z · Cited by 46
“MIF also exerts its pro-survival and anti-apoptotic effects through the activation of PI3K/Akt cascade [42].”
BackgroundStojanović, I., Saksida, T., Nikolić, I., Nicoletti, F., & Stošić‐Grujičić, S. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04607.x · Cited by 38
CD74: a new prognostic factor for patients with malignant pleural mesothelioma
Otterstrom, C. V., Soltermann, A., Opitz, I., Felley‐Bosco, E., Weder, W., Stahel, R. A., Triponez, F., Róbert, J., & Serre‐Beinier, V. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.117 · Cited by 36
An integrated signal transduction network of macrophage migration inhibitory factor
Subbannayya, T., Variar, P., Advani, J., Nair, B. G., Shankar, S., Gowda, H., Saussez, S., Chatterjee, A., & Prasad, T. S. K. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0326-x · Cited by 51
“contributes to the pro-survival and anti-apoptotic effects of MIF (Lue et al. 2007).”
BackgroundSchinagl, A., Kerschbaumer, R. J., Sabarth, N., Douillard, P., Scholz, P., Voelkel, D., Hollerweger, J. C., Goettig, P., Brandstetter, H., Scheiflinger, F., et al. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01156 · Cited by 33
Self-citationZhang, Y., Lu, S., Fan, S., Xu, L., Jiang, X., Wang, K., & Cai, B. (2021) · Aging · doi:10.18632/aging.202505 · Cited by 33
Ruvolo, P. P., Hu, C. W., Qiu, Y., Ruvolo, V. R., Go, R. L., Hubner, S. E., Coombes, K. R., Andreeff, M., Qutub, A. A., & Kornblau, S. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.025 · Cited by 33
The Role of Macrophage Migration Inhibitory Factor (MIF) in Asthmatic Airway Remodeling
Li, R., Wang, F., Wei, J., Lin, Y., Tang, G., Rao, L., Ma, L., Xu, Q., Wu, J., Lv, Q., et al. (2020) · Allergy Asthma and Immunology Research · doi:10.4168/aair.2021.13.1.88 · Cited by 33
Probing in vivo dendritic cell functions by conditional cell ablation
Sapoznikov, A., & Jung, S. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.23 · Cited by 36
Youness, R. A., Elemam, N. M., Abdelhamid, A. M., Mohamed, A. H., Elsherbiny, L. M., Ramzy, A., & Assal, R. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1636839 · Cited by 48
Girard, E., Strathdee, C. A., Trueblood, E. S., & Quéva, C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.392 · Cited by 35
“…of proliferation, apoptosis, DNA-damage response, senescence and invasion (Petrenko and Moll, 2005; Welford et al, 2006; Bucala and Donnelly, 2007; Fingerle-Rowson and Petrenko, 2007; Lue et al, 2007; Nemajerova et al, 2007b; Bifulco et al, 2008; Verjans et al, 2009; Dessein et al, 2010).”
BackgroundTerrazas, C. A., Huitron, E., Vázquez-Mendoza, A., Juárez, I., Camacho, G., Calleja, E. A., & Rodríguez‐Sosa, M. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1298 · Cited by 38
Pacheco‐Fernández, T., Juárez‐Avelar, I., Illescas, O., Terrazas, L. I., Hernández‐Pando, R., Pérez‐Plasencia, C., Gutiérrez-Cirlos, E. B., Ávila‐Moreno, F., Chirino, Y. I., Reyes, J. L., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/2056085 · Cited by 39
“Previous studies have demonstrated that MIF induces cellular proliferation by activating the ERK1-ERK2-MAPK [48] and AKT [49] pathways and suppresses JAB1 activity [47] and p53-mediated growth arrest and apoptosis [14, 50].”
Liu, R.-M., Sun, D., Jiao, Y.-L., Wang, P., Zhang, J., Wang, M., Ma, J., Sun, M., Gu, B., Chen, P., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.10.018 · Cited by 37
Zhang, H., Zhang, P., Lin, X., Tan, L., Wang, Y., Jia, X., Wang, K., Li, X., & Sun, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1366096 · Cited by 36
Pathogenic Roles of Macrophage Migration Inhibitory Factor during Dengue Virus Infection
Chuang, Y., Chen, H., & Yeh, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/547094 · Cited by 37
“CD44 is required for transmitting the MIF/CD74 signal by relaying the Src tyrosine kinase-mediated phosphorylation of serine on the cytosolic tail of CD74 and CD44; this phosphorylation then activates the downstream ERK/MAPK and PI3K/Akt pathways [16–18].”
BackgroundAzimi, A., Alexander, K. L., Ali, M., Arthur, J. W., Kossard, S., & Fernández‐Peñas, P. (2018) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2018.04.006 · Cited by 33
SHIN, H.-N., Moon, H., & Ku, J. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1141 · Cited by 39
“MIF activates AKT signaling, which is related to cell survival and induces the suppression of apoptosis in fibroblasts and breast cancer cells (44).”
Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown
Schrader, J., Deuster, O., Rinn, B., Schulz, M., Kautz, A., Dodel, R. C., Meyer, B., Al‐Abed, Y., Balakrishnan, K., Reese, J. P., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-464 · Cited by 31
“Indeed targeting MIF by neutralizing antibody has recently been shown to enhance chemotherapy efficacy in breast cancer cells [37].”
BackgroundThe role of CD74 in cardiovascular disease
Li, Q., Tang, J. Y., Zhao, L., Ruze, A., Shan, X., & Gao, X. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1049143 · Cited by 37
Huang, Q., Zhao, S.-L., Tian, X.-Y., Li, B., & Li, Z. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.5185 · Cited by 30
“Recent studies also demonstrated that MIF modulates the biological response in different cell types by inducing the nuclear factor-kappa B (NF-κB), Erk1/2 and activating protein-1(AP-1) signaling pathways, or by binding CD74/CD44 receptor complex [9-11].”
BackgroundLoyon, R., Picard, E., Mauvais, O., Queiroz, L., Mougey, V., Pallandre, J., Galaine, J., Mercier‐Letondal, P., Kellermann, G., Chaput, N., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501147 · Cited by 30
“1), NKp46 PE (9E2/NKp46), NKG2D PE (1D11), DNAM-1 PE (DX11), 2B4 PE (2-69) , IFN-g allophycocyanin (B27), TNF-a PE (MAb11), IL-2 allophycocyanin (MQ117H12), pY705 pSTAT3 PE (4/P-STAT3), pS727 pSTAT3 PE (49/p-Stat3), CXCR3 allophycocyanin (1C6/CXCR3), CCR6 BV510 (11A9), CCR4 PE (1G1), and CXCR5 BV510 (RF8B2) from BD Bi…”
Improved survival of mesenchymal stem cells by macrophage migration inhibitory factor
Xia, W., Xie, C., Jiang, M., & Hou, M. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2361-y · Cited by 30
“The phosphoinositide-3-kinase (PI3K)/Akt signaling pathway, which can be activated by MIF binding to CD74, functions in the cellular response to growth factors, and regulates key cellular functions including growth, metabolism, migration, apoptosis, and survival [17, 19, 20].”
Faria, M. F. D. O., Hoshida, M. S., Ferro, E. A. V., Ietta, F., Paulesu, L. R., & Bevilacqua, E. M. A. F. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-95 · Cited by 29
“One of the most known actions of MIF is its ability in promoting cell proliferation and suppressing apoptosis [6-8].”
BackgroundInfluentialHiress, M. L., Akagah, B., Bernadat, G., Tu, L., Thuillet, R., Huertas, A., Phan, C., Fadel, É., Simonneau, G., Humbert, M. J. C., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01312 · Cited by 32
β-Arrestin1 Mediates the Endocytosis and Functions of Macrophage Migration Inhibitory Factor
Xie, L., Qiao, X., Wu, Y., & Tang, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016428 · Cited by 35
Illescas, O., Pacheco‐Fernández, T., Laclette, J. P., Rodríguez, T., & Rodríguez‐Sosa, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155121 · Cited by 30
Guo, Y., Hou, J., Luo, Y., & Wang, D. (2013) · Cancer Cell International · doi:10.1186/1475-2867-13-28 · Cited by 30
“A number of reports have shown that MIF is capable of blocking p53-dependent apoptosis [46], and can activate the PI3K/Akt pathway [47,48], as well as promoting endothelial cell proliferation and differentiation [49-51].”
CD74 expression is increased in high‐grade, invasive urothelial carcinoma of the bladder
Choi, J., Kim, Y., Lee, J., & Kim, Y. (2012) · International Journal of Urology · doi:10.1111/j.1442-2042.2012.03128.x · Cited by 30
Asare, Y., Shagdarsuren, E., Schmid, J. A., Tilstam, P. V., Grommes, J., Bounkari, O. E., Schütz, A. K., Weber, C., de Winther, M. P. J., Noels, H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0155 · Cited by 30
“MIF impairs CSN5-mediated JNK/AP-1 transcriptional activity (49), CSN5 counter-regulates MIF secretion (51), an observation that would be supportive of an atheroprotective role for CSN5.”
BackgroundSelf-citationBeta cell function: the role of macrophage migration inhibitory factor
Stojanović, I., Saksida, T., & Stošić‐Grujičić, S. (2012) · Immunologic Research · doi:10.1007/s12026-012-8281-y · Cited by 29
“level, these functional activities include tumor suppressor down-regulation, COX-2/PGE2 up-regulation, and sustained ERK activation further resulting in the accumulation of mutations, inhibition of apoptosis, and promotion of tumor cell viability, cell cycle progression, invasion, and metastasis [24, 25, 56, 57].”
BackgroundRole of Inflammation in Polycystic Kidney Disease
CVMD iMed, B. C., & Karihaloo, A. (2015) · Codon Publications eBooks · doi:10.15586/codon.pkd.2015.ch14 · Cited by 32
Ney, J., Hoffmann, K., Meybohm, P., Goetzenich, A., Kraemer, S., Benstöm, C., Weber, N. C., Bickenbach, J., Rossaint, R., Marx, G., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041094 · Cited by 28
Self-citationCeccherini, E., Indovina, P., Zamperini, C., Dreassi, E., Casini, N., Cutaia, O., Forte, I. M., Pentimalli, F., Esposito, L., Polito, M. S., et al. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25042 · Cited by 27
“…a moderate intestinal absorption (Papp: 8.78 10 6 cm/s) of SI221 [Radi et al., 2013], this molecule could still have high in vivo efficacy after per os administration, as occurred previously with similar compounds having comparable predicted intestinal membrane permeability [Manetti et al., 2007].”
ResultInfluentialPohl, J., Hendgen-Cotta, U. R., Rammos, C., Luedike, P., Mull, E., Stoppe, C., Jülicher, K., Lue, H., Merx, M. W., Kelm, M., et al. (2015) · Thrombosis and Haemostasis · doi:10.1160/th15-05-0436 · Cited by 27
Self-citationHuang, S., Cao, Y., Lu, M., Peng, W., Lin, J., Tang, C., & Tang, L. (2017) · International Journal for Parasitology · doi:10.1016/j.ijpara.2017.01.005 · Cited by 32
Invariant Chain Complexes and Clusters as Platforms for MIF Signaling
Lindner, R. M. (2017) · Cells · doi:10.3390/cells6010006 · Cited by 31
“MIF-induced activation of the PI3K/Akt pathway resulted in the induction of anti-apoptotic factors (Bcl-2 and Bcl-XL), cell cycle regulators (Cyclin E) and NFκB activity in primary B-cells [29] and inhibitory phosphorylation of Bad, Foxo3a and GSK-3 in transformed fibroblasts [22].”
BackgroundInfluentialPandey, P., & Khan, F. (2020) · Nutrition and Cancer · doi:10.1080/01635581.2020.1826989 · Cited by 26
Casini, N., Forte, I. M., Mastrogiovanni, G., Pentimalli, F., Angelucci, A., Festuccia, C., Tomei, V., Ceccherini, E., Marzo, D. D., Schenone, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3043 · Cited by 28
“Conversely, consistent with the ability of various SFKs to activate antiapoptotic pathways [25, 26], we observed that SFK inhibition through SI221 induced apoptosis in RMS cell lines.”
Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases
Milic, J., Tian, Y., & Bernhagen, J. (2019) · Biomolecules · doi:10.3390/biom9060217 · Cited by 29
“As discussed in Section 1, intracellular MIF also directly interacts with CSN5 to control the JNK/AP-1 signaling pathway and p27-dependent cell cycle regulation, and inflammatory MIF secretion in endothelial and tumor cells was found to be controlled by CSN5 [90,114].”
BackgroundSelf-citationTargeting protein kinase-b3 (akt3) signaling in melanoma
Madhunapantula, S. V., & Robertson, G. P. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1279147 · Cited by 28
Jab1/Cops5: a promising target for cancer diagnosis and therapy
Yuan, C., Wang, D., Liu, G., & Pan, Y. (2021) · International Journal of Clinical Oncology · doi:10.1007/s10147-021-01933-9 · Cited by 27
TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment
Zhang, Z., Zhou, X., Guo, J. J., Zhang, F., Qian, Y., Wang, G., Duan, M., Wang, Y., Zhao, H., Yang, Z., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03528-y · Cited by 28
“[71] demonstrated that MIF protects tumor cells from apoptosis, promoting survival through activating the PI3K/AKT pathway mediated by CD74.”
BackgroundObata, T., Tsutsumi, K., Ueta, E., Oda, T., Kikuchi, T., Ako, S., Fujii, Y., Yamazaki, T., Uchida, D., Matsumoto, K., et al. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102054 · Cited by 26
Brocks, T., Fedorchenko, O., Schliermann, N., Stein, A., Moll, U. M., Seegobin, S., Dewor, M., Hallek, M. J., Marquardt, Y., Fietkau, K., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600860r · Cited by 27
Self-citation
Metadata
- Authors
- Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., & Bernhagen, J.
- Affiliations
- Universitätsklinikum Aachen (DE)
- Yale University (US)
- Corresponding author
- Bernhagen, J
- Venue
- Oncogene
- Published
- 2007-02-19
- Volume
- 26
- Issue
- 35
- Pages
- 5046-5059
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2047308155
- Cited by
- 385
- References
- 49
- Citations by year
- 2026: 10 · 2025: 19 · 2024: 14 · 2023: 15 · 2022: 23 · 2021: 29 · 2020: 14 · 2019: 24 · 2018: 20 · 2017: 20 · 2016: 23 · 2015: 27 · 2014: 23 · 2013: 20 · 2012: 29
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI43210)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR49610, R01AR049610)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Macrophage Migration Inhibitory Factor
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Keywords
- macrophage migration inhibitory factor, Akt signaling, PI3K/Akt signaling, cell survival, apoptosis inhibition, CD74, autocrine signaling, tumor cell survival, breast cancer, PTEN, Bad, FOXO3, p53-independent apoptosis, etoposide-induced apoptosis, Src kinase, tumor microenvironment
- MeSH terms
- COP9 Signalosome Complex, Animals, Antigens, Differentiation, B-Lymphocyte, Histocompatibility Antigens Class II, Breast Neoplasms, Cell Survival, Humans, Macrophage Migration-Inhibitory Factors, Neoplasms, Peptide Hydrolases, Phosphorylation, src-Family Kinases, Phosphatidylinositol 3-Kinases, Autocrine Communication, Cell Line, Tumor, Intracellular Signaling Peptides and Proteins, Proto-Oncogene Proteins c-akt, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.